Repo Dosen ULM

Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users

Show simple item record

dc.creator BAKHRIANSYAH, MOHAMMAD
dc.date.accessioned 2020-06-15T04:05:14Z
dc.date.available 2020-06-15T04:05:14Z
dc.identifier http://eprints.ulm.ac.id/8962/1/Risk_of_nephrotic_syndrome_for_NSAID_users.pdf
dc.identifier BAKHRIANSYAH, MOHAMMAD Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users. CJASN.
dc.identifier.uri https://repo-dosen.ulm.ac.id//handle/123456789/14039
dc.description Background and objectivesNonsteroidal anti-inflammatory drugs (NSAIDs) have been associatedwith AKI. Their association with nephrotic syndrome has not been systematically studied. This study aimed to assess the risk of nephrotic syndrome associated with NSAID use. Design, setting, participants, & measurements A matched case-control study was performed in the UK primary care database. Cases were patients with a first diagnosis of nephrotic syndrome and controls were those without nephrotic syndrome. NSAID exposure (grouped either based on cyclooxygenase enzyme selectivity and chemical groups) was classified as either current (use at the nephrotic syndrome diagnosis date and corresponding date in the control group), recent, or past use. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated using unconditional logistic regression analysis. Results We included 2620 cases and 10,454 controls. Compared with non-use, current use of 15–28 days and .28 days of conventional NSAIDs was associated with a higher relative risk of nephrotic syndrome: adjusted OR, 1.34; 95% CI, 1.06 to 1.70, and OR, 1.42; 95% CI, 0.79 to 2.55, respectively. Also, recent use (discontinuation 1–2 months before nephrotic syndrome diagnosis date; OR, 1.55; 95% CI, 1.11 to 2.15) and past use (discontinuation 2months-2 years; OR, 1.24; 95% CI, 1.07 to 1.43), but not current use of ,15 days (OR, 0.78; 95% CI, 0.46 to 1.31) nor past use (discontinuation .2 years; OR, 0.96; 95% CI, 0.85 to 1.09) were associated with a higher relative risk of nephrotic syndrome as well as past use of selective COX-2 inhibitors (discontinuation 2–24 months; OR, 1.24; 95% CI, 0.98 to 1.58). Categorization based on chemical groups showed that acetic acid and propionic acid derivatives were associated with a higher risk of nephrotic syndrome. Conclusions The use of conventional NSAIDs was associated with a higher risk of nephrotic syndrome starting from at least 2 weeks of exposure, as well as for recent and past exposure up to 2 years before the diagnosis of nephrotic syndrome. This higher risk appeared mainly attributable to acetic acid and propionic acid derivatives
dc.format text
dc.relation https://cjasn.asnjournals.org/content/14/9/1355.long
dc.relation http://eprints.ulm.ac.id/8962/
dc.subject Q Science (General)
dc.title Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users
dc.type Article
dc.type PeerReviewed


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account